National Bank of Canada’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$34.7M Buy
134,483
+44,909
+50% +$11.6M 0.03% 332
2025
Q1
$20.1M Buy
89,574
+51,453
+135% +$11.5M 0.02% 434
2024
Q4
$8.72M Sell
38,121
-28,530
-43% -$6.52M 0.01% 632
2024
Q3
$16.3M Buy
66,651
+19,120
+40% +$4.67M 0.02% 465
2024
Q2
$8.88M Buy
47,531
+6,014
+14% +$1.12M 0.01% 522
2024
Q1
$8.88M Buy
41,517
+3,323
+9% +$711K 0.01% 549
2023
Q4
$6.56M Buy
38,194
+3,802
+11% +$653K 0.01% 580
2023
Q3
$5.01M Buy
34,392
+6,893
+25% +$1M 0.01% 650
2023
Q2
$5.91M Buy
27,499
+14,397
+110% +$3.09M 0.01% 588
2023
Q1
$2.87M Buy
13,102
+5,833
+80% +$1.28M 0.01% 663
2022
Q4
$1.51M Buy
7,269
+2,943
+68% +$613K ﹤0.01% 861
2022
Q3
$964K Sell
4,326
-236
-5% -$52.6K 0.01% 867
2022
Q2
$978K Sell
4,562
-3,042
-40% -$652K ﹤0.01% 871
2022
Q1
$1.85M Buy
7,604
+3,328
+78% +$811K 0.01% 743
2021
Q4
$1.09M Buy
+4,276
New +$1.09M ﹤0.01% 877